Antonello E Rigamonti1, Valentina Bollati2, Laura Pergoli2, Simona Iodice2, Alessandra De Col3, Sofia Tamini3, Sabrina Cicolini3, Gabriella Tringali3, Roberta De Micheli3, Silvano G Cella4, Alessandro Sartorio3,5. 1. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. antonello.rigamonti@unimi.it. 2. Department of Clinical Sciences and Community Health, EPIGET Lab, University of Milan, Milan, Italy. 3. Experimental Laboratory for Auxo-endocrinological Research, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy. 4. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. 5. Division of Metabolic Disease and Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy.
Abstract
BACKGROUND: Exercise is recognized to evoke multisystemic adaptations that, particularly in obese subjects, reduce body weight, improve glucometabolic control, counteract sarcopenia, and lower the risk of cardiometabolic diseases. Understanding the molecular and cellular mechanisms of exercise-induced benefits is of great interest due to the therapeutic implications against obesity. OBJECTIVES AND METHODS: The aim of the present study was to evaluate time-related changes in size distribution and cell origin of extracellular vesicles (EVs) in obese and normal-weight subjects who underwent a moderate-intensity exercise on a treadmill (at 60% of their VO2max). Blood samples were drawn before, immediately at the end of the exercise and during the postexercise recovery period (3 and 24 h). Circulating EVs were analyzed by a nanoparticle tracking analysis and flow cytometry after labeling with the following cell-specific markers: CD14 (monocyte/macrophage), CD61 (platelet), CD62E (activated endothelium), CD105 (total endothelium), SCGA (skeletal muscle), and FABP (adipose tissue). RESULTS: In all subjects, acute exercise reduced the release of total (i.e., 30-700 nm) EVs in circulation, predominantly EVs in the microvesicle size range (i.e., 130-700 nm EVs). The postexercise release of microvesicles was higher in normal-weight than obese subjects; after exercise, circulating levels of exosomes (i.e., 30-130 nm EVs) and microvesicles were, respectively, lower and higher in females than males. In all experimental subgroups (males vs. females and obese vs. normal-weight subjects), acute exercise reduced and increased, respectively, CD61 + and SCGA + EVs, being the effect on CD61 + EVs prolonged up to 24 h after the end of the test with subjects in resting conditions. Total EVs, exosomes, and CD61 + EVs were associated with HOMA-IR. CONCLUSIONS: Though preliminary, the results of the present study show that a single bout of acute exercise modulates the release of EVs in circulation, which are tissue-, sex-, and BMI specific, suggesting that the exercise-related benefits might depend upon a complex interaction of tissue, endocrine, and metabolic factors.
BACKGROUND: Exercise is recognized to evoke multisystemic adaptations that, particularly in obese subjects, reduce body weight, improve glucometabolic control, counteract sarcopenia, and lower the risk of cardiometabolic diseases. Understanding the molecular and cellular mechanisms of exercise-induced benefits is of great interest due to the therapeutic implications against obesity. OBJECTIVES AND METHODS: The aim of the present study was to evaluate time-related changes in size distribution and cell origin of extracellular vesicles (EVs) in obese and normal-weight subjects who underwent a moderate-intensity exercise on a treadmill (at 60% of their VO2max). Blood samples were drawn before, immediately at the end of the exercise and during the postexercise recovery period (3 and 24 h). Circulating EVs were analyzed by a nanoparticle tracking analysis and flow cytometry after labeling with the following cell-specific markers: CD14 (monocyte/macrophage), CD61 (platelet), CD62E (activated endothelium), CD105 (total endothelium), SCGA (skeletal muscle), and FABP (adipose tissue). RESULTS: In all subjects, acute exercise reduced the release of total (i.e., 30-700 nm) EVs in circulation, predominantly EVs in the microvesicle size range (i.e., 130-700 nm EVs). The postexercise release of microvesicles was higher in normal-weight than obese subjects; after exercise, circulating levels of exosomes (i.e., 30-130 nm EVs) and microvesicles were, respectively, lower and higher in females than males. In all experimental subgroups (males vs. females and obese vs. normal-weight subjects), acute exercise reduced and increased, respectively, CD61 + and SCGA + EVs, being the effect on CD61 + EVs prolonged up to 24 h after the end of the test with subjects in resting conditions. Total EVs, exosomes, and CD61 + EVs were associated with HOMA-IR. CONCLUSIONS: Though preliminary, the results of the present study show that a single bout of acute exercise modulates the release of EVs in circulation, which are tissue-, sex-, and BMI specific, suggesting that the exercise-related benefits might depend upon a complex interaction of tissue, endocrine, and metabolic factors.
Authors: A Sartorio; C L Lafortuna; N A Maffiuletti; F Agosti; N Marazzi; F Rastelli; A E Rigamonti; E E Muller Journal: Growth Horm IGF Res Date: 2010-10-12 Impact factor: 2.372
Authors: Xiaochen Lin; Xi Zhang; Jianjun Guo; Christian K Roberts; Steve McKenzie; Wen-Chih Wu; Simin Liu; Yiqing Song Journal: J Am Heart Assoc Date: 2015-06-26 Impact factor: 5.501
Authors: A E Rigamonti; M Haenelt; M Bidlingmaier; A De Col; S Tamini; G Tringali; R De Micheli; L Abbruzzese; C R Goncalves da Cruz; M Bernardo-Filho; S G Cella; A Sartorio Journal: BMC Endocr Disord Date: 2018-12-27 Impact factor: 2.763
Authors: Emily M Heiston; Anna Ballantyne; Sabrina La Salvia; Luca Musante; Uta Erdbrügger; Steven K Malin Journal: J Physiol Date: 2022-01-26 Impact factor: 6.228
Authors: Chiara Macchi; Maria Francesca Greco; Chiara Favero; Laura Dioni; Laura Cantone; Mirjam Hoxha; Luisella Vigna; Giulia Solazzo; Alberto Corsini; Maciej Banach; Angela C Pesatori; Valentina Bollati; Massimiliano Ruscica Journal: Front Cardiovasc Med Date: 2022-01-07
Authors: Matthew Nayor; Ravi V Shah; Patricia E Miller; Jasmine B Blodgett; Melissa Tanguay; Alexander R Pico; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Amy Deik; Kerry A Pierce; Kevin Bullock; Lucas Dailey; Raghava S Velagaleti; Stephanie A Moore; Jennifer E Ho; Aaron L Baggish; Clary B Clish; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Circulation Date: 2020-09-15 Impact factor: 29.690